Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against Alpha, Beta, Delta and Omicron variants of concern

J Travel Med. 2022 May 31;29(3):taac039. doi: 10.1093/jtm/taac039.

Affiliations

¹ Indian Council of Medical Research-National Institute of Virology, MCC 130/1 Sus Road, Pashan, Pune, Maharashtra 411021, India.
² Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India.
³ Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India.

PMID: 35325176
DOI: 10.1093/jtm/taac039

No abstract available

Keywords: Covaxin; booster dose; neutralizing antibody; variants of concern.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Neutralizing
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccines, Inactivated

Substances

Antibodies, Neutralizing
COVID-19 Vaccines
Vaccines, Inactivated

Supplementary concepts

SARS-CoV-2 variants